Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 3, 2011, Pages 339-349

  Locatelli, Franco ^a   Vinti, Luciana ^a,c   Palumbo, Giuseppe ^a,b   Rossi, Francesca ^c   Bertaina, Alice ^a   Mastronuzzi, Angela ^a   Bernardo, Maria Ester ^a   Rutella, Sergio ^d   Dellabona, Paolo ^e   Giorgiani, Giovanna ^f   Moretta, Alessandro ^g   Moretta, Lorenzo ^g  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

Author keywords

cellular therapy; graft versus leukemia effect; invariant NKT cells; mesenchymal stromal cells; NK alloreactivity; pathogen specific T cells

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADENOVIRUS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; ASPERGILLUS; B LYMPHOCYTE; CELL FUNCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; EPSTEIN BARR VIRUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; LEUKEMIA; LEUKEMIA RELAPSE; MESENCHYMAL STEM CELL; MESENCHYME CELL; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REMISSION; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 80053024772     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.04.004     Document Type: Review

References (70)

1. R.A. Gatti, H.J. Meuwissen, and H.D. Allen Immunological reconstitution of sex linked lymphopenic immunological deficiency Lancet 2 1968 1366 1369
2. F.M. Bach, M.J. Albertini, and P. Joho Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome Lancet 2 1968 1364 1366
3. E.A. Copelan Hematopoietic stem cell transplantation N Engl J Med 354 2006 1813 1826
4. F. Locatelli, and G.R. Burgio Transplant of haematopoietic stem cells in childhood: where we are and where we are going Haematologica 83 1998 550 563 (Pubitemid 28331174)
5. V. Rocha, and F. Locatelli Searching for alternative donors of haematopoietic stem cell for paediatric patients Bone Marrow Transplant 41 2008 207 214 (Pubitemid 351188919)
6. F. Ciceri, M. Labopin, and F. Aversa A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation Blood 112 2008 3574 3581
7. T. Klingebiel, J. Cornish, and M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplant in children with very-high risk acute lymphoblastic leukemia - impact of center size: an analysis on behalf of the Acute Leukemia and pediatric disease working parties of the European blood and marrow transplant group Blood 115 2010 3437 3446
8. M.F. Martelli, F. Aversa, and E. Bachar-Lustig Transplants across human leukocyte antigen barriers Semin Hematol 39 2002 48 56 (Pubitemid 34081156)
9. Y. Reisner, N. Kapoor, and D. Kirkpatrick Transplantation for severe combined immunodeficiency with HLA-A, BD, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 61 1983 341 348 (Pubitemid 13137655)
10. Y. Reisner, and F. Martelli Stem cell escalation enables HLA-disparate hematopoietic transplants in leukaemia patients Immunol Today 20 1999 343 347 (Pubitemid 29356426)
11. E. Bachar-Lustig, N. Rachamim, and H.W. Li Megadose of T-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med 1 1995 1268 1273
12. F. Aversa, A. Tabilio, and A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
13. F. Aversa, A. Tabilio, and A. Velardi Treatment of high risk acute leukaemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype N Eng J Med 339 1998 1186 1193 (Pubitemid 28482127)
14. F. Aversa, A. Terenzi, and A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
15. D.I. Marks, N. Khattry, and M. Cummins Haploidentical stem cell transplantation for children with acute leukaemia Br J Haematol 134 2006 196 201 (Pubitemid 43893912)
16. P. Lang, J. Greil, and P. Bader Long-term outcome after haploidentical stem cell transplantation in children Blood Cells Mol Dis 33 2004 281 287 (Pubitemid 39446500)
17. A. Moretta, D. Pende, and F. Locatelli Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias Clin Exp Immunol 157 2009 325 331
18. M. Stern, L. Ruggeri, and A. Mancusi Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor Blood 112 2008 2990 2995
19. M.M. Horowitz, R.P. Gale, and P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555 562 (Pubitemid 20069191)
20. F. Locatelli, D. Pende, and R. Maccario Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference Clin Immunol 133 2009 171 178
21. A. Moretta, F. Locatelli, and L. Moretta Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias Immunol Rev 224 2008 58 69
22. T.J. Fry, and C.L. Mackall Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future Bone Marrow Transplant 35 Suppl. 1 2005 S53 S57
23. E.B. Papadopoulos, M. Ladanyi, and D. Emanuel Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation N Engl J Med 330 1994 1185 1191 (Pubitemid 24121987)
24. C. Bonini, G. Ferrari, and S. Verzeletti HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft versus leukemia Science 276 1997 1719 1724 (Pubitemid 27421983)
25. F. Ciceri, C. Bonini, and M.T. Stanghellini Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study Lancet Oncol 10 2009 489 500
26. P.J. Amrolia, G. Muccioli-Casadei, and H. Huls Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation Blood 108 2006 1797 1808 (Pubitemid 44394986)
27. B.J. Chen, X. Cui, and C. Liu Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process Blood 99 2002 3083 3088 (Pubitemid 34525284)
28. D.C. Roy, S. Lachance, and T. Kiss Haploidentical stem cell transplantation: high doses of alloreactie-T cell depleted donor lymphocytes administered post-transplant decrease infections and improve survival without causing severe GVHD Blood 2009 (ASH Annual Meeting Abstracts) 114: abstract 512
29. M.D. Ianni, F. Falzetti, and A. Carotti Adoptive immunotherapy with tregs prevents GvHD and favours immune reconstitution after HLA haploidentical transplants for hematological malignancies Blood 2009 (ASH Annual Meeting Abstracts) 114: abstract 4
30. K. Perruccio, A. Tosti, and E. Burchielli Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation Blood 106 2005 4397 4406 (Pubitemid 41775954)
31. T. Feuchtinger, S. Matthes-Martin, and C. Richard Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation Br J Haematol 134 2006 64 76 (Pubitemid 43830030)
32. P. Comoli, S. Basso, and M. Zecca Preemptive treatment of EBV-related post-transplant lymphoproliferative disorders after pediatric haploidentical stem cell transplantation Am J Transplant 7 2007 1648 1655 (Pubitemid 46776261)
33. H.E. Heslop, C.Y.C. Ng, and C. Li Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat Med 2 1996 551 555 (Pubitemid 26150682)
34. C.M. Rooney, C.A. Smith, and C.Y.C. Ng Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1998 1549 1555 (Pubitemid 28406858)
35. C.M. Rooney, C.A. Smith, and C.Y. Ng Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation Lancet 345 1995 9 12
36. E.A. Walter, P.J. Greenberg, and M.J. Gilbert Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038 1044
37. H. Einsele, E. Roosnek, and N. Rufer Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviralchemotherapy Blood 99 2002 3916 3922 (Pubitemid 35332029)
38. T. Walls, A.G. Shankar, and D. Shingadia Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients Lancet Infect Dis 3 2003 79 86 (Pubitemid 36164203)
39. S. Chakrabarti, V. Mautner, and H. Osman Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression and immune recovery Blood 100 2002 1619 1627 (Pubitemid 34925137)
40. T. Lion, R. Baumgartinger, and F. Watzinger Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease Blood 102 2003 1114 1120 (Pubitemid 36917814)
41. P. Comoli, M.W. Schilham, and S. Basso T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors J Immunother 31 2008 529 536
42. A.M. Leen, G.D. Myers, and U. Sili Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals Nat Med 12 2006 1160 1166 (Pubitemid 44527351)
43. F. Locatelli The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukemia relapsing following allogeneic transplantation Br J Haematol 102 1998 633 638 (Pubitemid 28387043)
44. F. Locatelli, and P. De Stefano T-cell depletion to prevent GVHD after unrelated-donor marrow transplantation Lancet 366 2005 692 694 (Pubitemid 41207218)
45. L. Moretta, F. Locatelli, and D. Pende Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation Blood 117 2011 764 771
46. A. Moretta, C. Bottino, and M.C. Mingari What is a Natural Killer cell? Nat Immunol 3 2002 6 8 (Pubitemid 34065607)
47. M. Caligiuri Human natural killer cells Blood 112 2008 461 469
48. L. Moretta, C. Bottino, and D. Pende Surface NK receptors and their ligands on tumor cells Semin Immunol 18 2006 151 158 (Pubitemid 43817561)
49. H.G. Ljunggren, and K. Karre In search of the "missing self". MHC molecules and NK cell recognition Immunol Today 11 1990 237 244 (Pubitemid 20198988)
50. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100 (Pubitemid 34229476)
51. D. Pende, S. Marcenaro, and M. Falco Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity Blood 113 2009 3119 3129
52. C. Bottino, R. Castriconi, and L. Moretta Cellular ligands for activating NK receptors Trends Immunol 26 2005 221 226
53. L. Moretta, C. Bottino, and D. Pende Different checkpoints in human NK-cell activation Trends Immunol 25 2004 670 676 (Pubitemid 39457981)
54. D. Pende, G.M. Spaggiari, and S. Marcenaro Analysis of the receptor-ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias. Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112) Blood 105 2005 2066 2073 (Pubitemid 40731793)
55. W.D. Shlomchik, M.S. Couzens, and C.B. Tang Prevention of graft versus host disease by inactivation of host antigen-presenting cells Science 285 1999 412 415 (Pubitemid 29343964)
56. L. Vago, B. Forno, and M.P. Sormani Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation Blood 112 2008 3488 3499
57. F. Locatelli, R. Maccario, and F. Frassoni Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica 92 2007 872 877 (Pubitemid 350144232)
58. M.E. Bernardo, F. Locatelli, and W.E. Fibbe Mesenchymal stromal cells: a novel treatment modality for tissue repair Ann N Y Acad Sci 1176 2009 101 117
59. + T-cell subsets expressing regulatory/suppressive phenotype Haematologica 90 2005 516 525 (Pubitemid 40592895)
60. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506 (Pubitemid 350159613)
61. + cells in NOD/SCID mice Exp Hematol 31 2003 881 889 (Pubitemid 37211372)
62. G. Almeida-Porada, A.W. Flake, and H.A. Glimp Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero Exp Hematol 27 1999 1569 1575 (Pubitemid 29458432)
63. H.M. Lazarus, O.N. Koc, and S.M. Devine Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients Biol Blood Marrow Transplant 11 2005 389 398 (Pubitemid 40542932)
64. L.M. Ball, M.E. Bernardo, and H. Roelofs Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation Blood 110 2007 2764 2767 (Pubitemid 47523204)
65. A. Bendelac, P.B. Savage, and L. Teyton The biology of NKT cells Annu Rev Immunol 25 2007 297 336 (Pubitemid 46697911)
66. D.I. Godfrey, and M. Kronenberg Going both ways: immune regulation via CD1d-dependent NKT cells J Clin Invest 114 2004 1379 1388 (Pubitemid 40385565)
67. E.S. Morris, K.P. MacDonald, and V. Rowe NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs J Clin Invest 115 2005 3093 3103 (Pubitemid 41567574)
68. L. Song, S. Asgharzadeh, and J. Salo Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages J Clin Invest 119 6 2009 1524 1536
69. Y. Hayakawa, K. Takeda, and H. Yagita IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide Blood 100 2002 1728 1733 (Pubitemid 34925151)
70. C. De Lalla, A. Rinaldi, and D. Montagna iNKT cell reconstitution in paediatric leukaemia patients following haploidentical stem cell transplantation suggests contribution to leukaemia control and reveals independent CD4+ and CD4-subset maturation programmes Bone Marrow Transplant 45 2010 S206 [S]